An Update on the Immunopathology of Immune Thrombocytopenia (ITP)

Pathology - United States
doi 10.1016/j.pathol.2020.01.136
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Highly Fluctuating Thrombocytopenia Developing in a Patient With Immune Thrombocytopenia (ITP) While Administering Romiplostim

Internal Medicine
Internal MedicineMedicine
2012English

P340 Case Report: Immune Thrombocytopenia Purpura (ITP) – An Intra-Oral and Extra-Oral Presentation

2019English

Eltrombopag: An Update on the Novel, Non-Peptide Thrombopoietin Receptor Agonist for the Treatment of Immune Thrombocytopenia

Annals of Hematology
MedicineHematology
2010English

A United Kingdom Immune Thrombocytopenia (ITP) Forum Review of Practice: Thrombopoietin Receptor Agonists

British Journal of Haematology
Hematology
2016English

Identification of Novel Biomarkers in Chronic Immune Thrombocytopenia (ITP) by Microarray-Based Serum Protein Profiling

British Journal of Haematology
Hematology
2015English

Determining the Cost of a Bleeding-Related Episode in Primary Adult Chronic Immune Thrombocytopenia (ITP) in the United States

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Immune Thrombocytopenia

Hospital Medicine Clinics
Medicine
2017English

Is There a Role for Biweekly Romiplostim in the Management of Chronic Immune Thrombocytopenia (ITP)? A Report of Three Cases

Case Reports in Hematology
2018English

Thrombopoetin Receptor Agonist Therapy in Thrombocytopenia: ITP and Beyond

British Journal of Haematology
Hematology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy